Ligand to Participate in September Investor Conferences

Core Insights - Ligand Pharmaceuticals will participate in upcoming investor conferences, providing opportunities for one-on-one meetings with investors [1][4] Company Overview - Ligand Pharmaceuticals is a biopharmaceutical company focused on supporting the clinical development of high-value medicines through financing and licensing technologies [2] - The company's business model aims to create a diversified portfolio of biotech and pharmaceutical product revenue streams while maintaining a low corporate cost structure [2] - Ligand partners with leading pharmaceutical companies to leverage their expertise in late-stage development, regulatory management, and commercialization [2] - The company operates two royalty-generating technology platforms: Captisol® for optimizing drug solubility and stability, and NITRICIL™ for tunable dosing and adjustable drug release profiles [2] Investor Relations - Ligand utilizes its investor relations website and social media to disclose material non-public information and comply with disclosure obligations [3] - Investors are encouraged to monitor the company's website and social media accounts for updates, press releases, SEC filings, and conference calls [3]